REZOLUTE, INC. Other Income
REZOLUTE, INC. (RZLT) reported Other Income of $13.00 thousand for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-09.
Discontinued › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2022-02-09
- REZOLUTE, INC. other income for the quarter ending 2021-12-31 was $13.00K, a 76.36% decline year-over-year.
- REZOLUTE, INC. other income for the quarter ending 2020-12-31 was $55.00K.
| Period end | Other Income 3 month | Other Income 6 month |
|---|---|---|
| 2021-12-31 | $13.00K 10-Q · filed 2022-02-09 | $13.00K 10-Q · filed 2022-02-09 |
| 2020-12-31 | $55.00K 10-Q · filed 2022-02-09 | $58.00K 10-Q · filed 2022-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |